Difference between revisions of "Liang J"
From Bioblast
Beno Marija (talk | contribs) ย |
|||
Line 15: | Line 15: | ||
==Participated at== | ==Participated at== | ||
::::* [[IOC36]] | ::::* [[IOC36| IOC36 Schroecken AT]] |
Latest revision as of 15:02, 12 February 2018
Name | Liang Jinsheng, Dr. |
---|---|
Institution | |
Address | Novartis Institutes for BioMedical Research, Inc.
Diabetes & Metabolism 100 Technology Square Cambridge, MA 02139, USA, |
City | |
State/Province | |
Country | |
jinsheng.liang@novartis.com | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Liang 2019 Front Microbiol | 2019 | Liang J, Huang H, Wang S (2019) Distribution, evolution, catalytic mechanism, and physiological functions of the flavin-based electron-bifurcating NADH-dependent reduced ferredoxin: NADP+ oxidoreductase. Front Microbiol 10:373. https://doi.org/10.3389/fmicb.2019.00373 |
Strub 2011 FASEB J | 2011 | Strub GM, Paillard M, Liang J, Gomez L, Allegood JC, Hait NC, Maceyka M, Price MM, Chen Q, Simpson DC, Kordula T, Milstien S, Lesnefsky EJ, Spiegel S (2011) Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate Complex IV assembly and respiration. FASEB J 25:600-12. |